2016
DOI: 10.4238/gmr.15027955
|View full text |Cite
|
Sign up to set email alerts
|

Genetic variability in isolates of Chromobacterium violaceum from pulmonary secretion, water, and soil

Abstract: ABSTRACT. Chromobacterium violaceum is a free-living Gramnegative bacillus usually found in the water and soil in tropical regions, which causes infections in humans. Chromobacteriosis is characterized by rapid dissemination and high mortality. The aim of this study was to detect the genetic variability among C. violaceum type strain ATCC 12472, and seven isolates from the environment and one from a pulmonary secretion from a chromobacteriosis patient from Ilhéus, Bahia. The molecular characterization of all s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 18 publications
(23 reference statements)
0
2
0
Order By: Relevance
“…Bacteria from the genus Chromobacterium are highly abundant in nature and have been isolated from a wide variety of environments (39)(40)(41)(42)(43)(44). As such, any insecticidal compounds they produce are likely already present in nature, although not at the levels that would be found during a field trial of a Chromobacterium-based biopesticide.…”
Section: Discussionmentioning
confidence: 99%
“…Bacteria from the genus Chromobacterium are highly abundant in nature and have been isolated from a wide variety of environments (39)(40)(41)(42)(43)(44). As such, any insecticidal compounds they produce are likely already present in nature, although not at the levels that would be found during a field trial of a Chromobacterium-based biopesticide.…”
Section: Discussionmentioning
confidence: 99%
“…New therapeutic approaches would be needed to bring meaningful clinical benefit to patients (Romano et al, ; Rudin & Poirier, ; Santini, Magalhaes, Cascardo, & Correa, ). The real possibility to increase patient's survival is to identify new biomarkers or noninvasive device to differentiate benign from malignant lung lesions to obtain an early diagnosis and an accurate staging of NSCLC (Chimenti et al, ; Di Domenico & Giordano, ; Lamberti et al, ).…”
Section: Introductionmentioning
confidence: 99%